148 related articles for article (PubMed ID: 36590993)
1. Seroprevalence of hepatitis C virus antigen in patients with chronic liver disease and hepatocellular carcinoma at 12
Mbaga DS; Bikoï JN; Okobalemba EA; Essindi JO; Mikangue CAM; Membangbi AE; Ngoutane A; Elang AF; Touangnou-Chamda SA; Sake CS; Mondinde GI; Kenmoe S; Essama SHR
Pan Afr Med J; 2022; 43():72. PubMed ID: 36590993
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus infection in chronic liver disease in Natal.
Soni PN; Tait DR; Gopaul W; Sathar MA; Simjee AE
S Afr Med J; 1996 Jan; 86(1):80-3. PubMed ID: 8685789
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of hepatitis C: related hepatocellular carcinoma in Cameroon.
Andoulo FA; Noah DN; Djapa R; Kowo M; Talla P; Medjo EH; Djomkam IK; Nonga BN; Njoya O; Ndam EC
Pan Afr Med J; 2014; 19():379. PubMed ID: 25977742
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia.
Dondog B; Lise M; Dondov O; Baldandorj B; Franceschi S
Eur J Cancer Prev; 2011 Jan; 20(1):33-9. PubMed ID: 21166097
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
Resnick RH; Koff R
Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
[TBL] [Abstract][Full Text] [Related]
6. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
[TBL] [Abstract][Full Text] [Related]
7. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
Goldberg D; Ditah IC; Saeian K; Lalehzari M; Aronsohn A; Gorospe EC; Charlton M
Gastroenterology; 2017 Apr; 152(5):1090-1099.e1. PubMed ID: 28088461
[TBL] [Abstract][Full Text] [Related]
8. Status quo of chronic liver diseases, including hepatocellular carcinoma, in Mongolia.
Jazag A; Puntsagdulam N; Chinburen J
Korean J Intern Med; 2012 Jun; 27(2):121-7. PubMed ID: 22707881
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection and chronic liver disease in Ethiopia where hepatitis B infection is hyperendemic.
Tsega E; Nordenfelt E; Hansson BG
Trans R Soc Trop Med Hyg; 1995; 89(2):171-4. PubMed ID: 7539952
[TBL] [Abstract][Full Text] [Related]
10. A clinical and molecular epidemiological survey of hepatitis C in Blantyre, Malawi, suggests a historic mechanism of transmission.
Stockdale AJ; Kreuels B; Shawa IT; Meiring JE; Thindwa D; Silungwe NM; Chetcuti K; Joekes E; Mbewe M; Mbale B; Patel P; Kachala R; Patel PD; Malewa J; Finch P; Davis C; Shah R; Tong L; da Silva Filipe A; Thomson EC; Geretti AM; Gordon MA
J Viral Hepat; 2022 Apr; 29(4):252-262. PubMed ID: 35075742
[TBL] [Abstract][Full Text] [Related]
11. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
[TBL] [Abstract][Full Text] [Related]
12. Surveillance factors change outcomes in patients with hepatocellular carcinoma due to chronic hepatitis C virus infection in New Zealand.
Schauer C; van Rijnsoever M; Gane E
J Viral Hepat; 2019 Dec; 26(12):1372-1376. PubMed ID: 31323163
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of chronic hepatitis C infection in a low-prevalence area.
Verbaan H; Hoffmann G; Lindgren S; Nilsson S; Widell A; Eriksson S
Scand J Gastroenterol; 1998 Jun; 33(6):650-5. PubMed ID: 9669639
[TBL] [Abstract][Full Text] [Related]
14. Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical features.
Farinati F; Fagiuoli S; De Maria N; Chiaramonte M; Aneloni V; Ongaro S; Salvagnini M; Naccarato R
J Hepatol; 1992 Mar; 14(2-3):183-7. PubMed ID: 1380021
[TBL] [Abstract][Full Text] [Related]
15. A prominent role of Hepatitis D Virus in liver cancers documented in Central Africa.
Amougou MA; Noah DN; Moundipa PF; Pineau P; Njouom R
BMC Infect Dis; 2016 Nov; 16(1):647. PubMed ID: 27821080
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of hepatitis C virus with different genotypes determined by a group-specific antibody assay in Japanese patients with chronic liver diseases due to hepatitis C virus infection.
Tanaka E; Kiyosawa K; Matsumoto A; Sodeyama T; Urushihara A; Suzuki T; Kobayashi M; Furuta S
Jpn J Med Sci Biol; 1994 Feb; 47(1):47-57. PubMed ID: 7967159
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.
Kramer JR; El-Serag HB; Taylor TJ; White DL; Asch SM; Frayne SM; Cao Y; Smith DL; Kanwal F
J Viral Hepat; 2017 Nov; 24(11):955-965. PubMed ID: 28815822
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C: frequency and risk factors associated with sero-positivity among adults in Larkana City.
Shaikh FH; Ali Abro H; Ali Chhutto M; Abbasi PA; Shaikh AW; Ali Buriro S
J Ayub Med Coll Abbottabad; 2009; 21(2):107-9. PubMed ID: 20524483
[TBL] [Abstract][Full Text] [Related]
19. Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients.
Salmon-Ceron D; Nahon P; Layese R; Bourcier V; Sogni P; Bani-Sadr F; Audureau E; Merchadou L; Dabis F; Wittkop L; Roudot-Thoraval F;
Hepatology; 2019 Sep; 70(3):939-954. PubMed ID: 30569448
[TBL] [Abstract][Full Text] [Related]
20. Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C.
Reddy A; May E; Ehrinpreis M; Mutchnick M
World J Gastroenterol; 2013 Dec; 19(48):9328-33. PubMed ID: 24409059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
